Diadema Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,115
Closed -$3.54M 49
2025
Q1
$3.54M Buy
+13,115
New +$3.54M 0.92% 9